Viewing Study NCT05697575



Ignite Creation Date: 2024-05-06 @ 6:31 PM
Last Modification Date: 2024-10-26 @ 2:50 PM
Study NCT ID: NCT05697575
Status: RECRUITING
Last Update Posted: 2023-02-03
First Post: 2023-01-14

Brief Title: Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
Sponsor: National Society for Neurosonology and Cerebral Circulation
Organization: National Society for Neurosonology and Cerebral Circulation

Study Overview

Official Title: Non-interventional Observational Study to Evaluate the Efficacy and Safety of Non-immune Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
Status: RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: REPIN
Brief Summary: The study will collect data from aged 18 to 85 years with a diagnosis of acute stroke who received thrombolytic treatment with a new agent nonimmunogenic staphylokinase Outcomes will be checked for safety and compared to the results of treatment with the other thrombolytic drug alteplase
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None